83 related articles for article (PubMed ID: 3028818)
1. Early events in human B cell activation: metabolic pathways vary according to the first signal used.
Dugas B; Vazquez A; Klein B; Delfraissy JF; Rammou M; Gerard JP; Galanaud P
Eur J Immunol; 1986 Dec; 16(12):1609-14. PubMed ID: 3028818
[TBL] [Abstract][Full Text] [Related]
2. Human B cell activation: selective sensitivity of the early stages to calcium channel-blocking drugs.
Dugas B; Vazquez A; Delfraissy JF; Gérard JP; Rannou MT; Galanaud P
Eur J Immunol; 1986 Feb; 16(2):162-7. PubMed ID: 2420605
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of interleukin 2- and interleukin 4-mediated human B cell proliferation by ionomycin: a possible regulatory role for apoptosis.
Vazquez A; Auffredou MT; Chaouchi N; Taieb J; Sharma S; Galanaud P; Leca G
Eur J Immunol; 1991 Oct; 21(10):2311-6. PubMed ID: 1915547
[TBL] [Abstract][Full Text] [Related]
4. Activation and infection of B cells by Epstein-Barr virus. Role of calcium mobilization and of protein kinase C translocation.
Dugas B; Delfraissy JF; Calenda A; Peuchmaur M; Wallon C; Rannou MT; Galanaud P
J Immunol; 1988 Dec; 141(12):4344-51. PubMed ID: 2848895
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
7. Activation and proliferation signals in mouse B cells. VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetate.
Klaus GG; O'Garra A; Bijsterbosch MK; Holman M
Eur J Immunol; 1986 Jan; 16(1):92-7. PubMed ID: 3485050
[TBL] [Abstract][Full Text] [Related]
8. Antibody to a novel 95-kDa surface glycoprotein on human B cells induces calcium mobilization and B cell activation.
Valentine MA; Clark EA; Shu GL; Norris NA; Ledbetter JA
J Immunol; 1988 Jun; 140(12):4071-8. PubMed ID: 3259604
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane ion conductance in human B lymphocyte activation.
Brent LH; Butler JL; Woods WT; Bubien JK
J Immunol; 1990 Oct; 145(8):2381-9. PubMed ID: 1698853
[TBL] [Abstract][Full Text] [Related]
10. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
11. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
Davis L; Lipsky PE
J Immunol; 1986 May; 136(10):3588-96. PubMed ID: 3486215
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cell division of mature B cells by ionomycin and phorbol ester.
Kim KM; Ishigami T; Hata D; Yamaoka K; Mayumi M; Mikawa H
J Immunol; 1992 Mar; 148(6):1797-803. PubMed ID: 1541820
[TBL] [Abstract][Full Text] [Related]
13. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
Francois DT; Katona IM; June CH; Wahl LM; Feuerstein N; Huang KP; Mond JJ
J Immunol; 1988 May; 140(10):3338-43. PubMed ID: 3129493
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human B cell responsiveness by prostaglandin E2.
Simkin NJ; Jelinek DF; Lipsky PE
J Immunol; 1987 Feb; 138(4):1074-81. PubMed ID: 3027169
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
Rigley KP; Callard RE
Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
[TBL] [Abstract][Full Text] [Related]
16. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
Suzuki T; Butler JL; Cooper MD
J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
[TBL] [Abstract][Full Text] [Related]
17. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
[TBL] [Abstract][Full Text] [Related]
18. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP can enhance mouse B cell activation by regulating progression into the late G1/S phase.
Li YS; Kouassi E; Revillard JP
Eur J Immunol; 1989 Sep; 19(9):1721-5. PubMed ID: 2551697
[TBL] [Abstract][Full Text] [Related]
20. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
